Literature DB >> 24188576

Synthesis and characterization of ethosomal contrast agents containing iodine for computed tomography (CT) imaging applications.

Hanjin Shin1, Young-Min Cho, Kangtaek Lee, Chang-Ha Lee, Byoung Wook Choi, Bumsang Kim.   

Abstract

As a first step in the development of novel liver-specific contrast agents using ethosomes for computed tomography (CT) imaging applications, we entrapped iodine within ethosomes, which are phospholipid vesicular carriers containing relatively high alcohol concentrations, synthesized using several types of alcohol, such as methanol, ethanol, and propanol. The iodine containing ethosomes that were prepared using methanol showed the smallest vesicle size (392 nm) and the highest CT density (1107 HU). The incorporation of cholesterol into the ethosomal contrast agents improved the stability of the ethosomes but made the vesicle size large. The ethosomal contrast agents were taken up well by macrophage cells and showed no cellular toxicity. The results demonstrated that ethosomes containing iodine, as prepared in this study, have potential as contrast agents for applications in CT imaging.

Entities:  

Keywords:  Computed tomography (CT); contrast agents; ethosomes; iodine; liver; macrophage

Mesh:

Substances:

Year:  2013        PMID: 24188576     DOI: 10.3109/08982104.2013.850592

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  2 in total

Review 1.  Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials.

Authors:  Ibrahim M Abdulbaqi; Yusrida Darwis; Nurzalina Abdul Karim Khan; Reem Abou Assi; Arshad A Khan
Journal:  Int J Nanomedicine       Date:  2016-05-25

2.  Novel Biocompatible Au Nanostars@PEG Nanoparticles for In Vivo CT Imaging and Renal Clearance Properties.

Authors:  Daiyuan Tang; Wei Gao; Yajiang Yuan; Lingling Guo; Xifan Mei
Journal:  Nanoscale Res Lett       Date:  2017-10-12       Impact factor: 4.703

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.